Most men should have a conversation with their doctor about prostate cancer screening between ages 45 and 50, depending on their risk factors. There’s no single age that applies to everyone. Guidelines from major medical organizations vary slightly, but they converge on the idea that screening is a personal decision shaped by your age, race, and family history.
Starting Ages by Risk Level
For men at average risk with no family history of prostate cancer, most guidelines recommend beginning the screening conversation around age 50. The European Association of Urology echoes this, placing the standard starting point at 50 for the general population. The National Comprehensive Cancer Network and Memorial Sloan Kettering support starting the discussion at 45 after a shared decision-making conversation with your doctor.
If you’re Black or have a father or brother who was diagnosed with prostate cancer, the timeline moves earlier. Black men face roughly twice the risk of dying from prostate cancer compared to white men, and guidelines from the Prostate Cancer Foundation recommend baseline testing between ages 40 and 45. Research published in the New England Journal of Medicine Evidence estimated that lowering the screening start age to 40 to 45 for Black men could reduce prostate cancer deaths by about 30% without significantly increasing overdiagnosis. Men with a first-degree relative who had prostate cancer are similarly advised to start at 45.
Men who carry inherited genetic mutations that raise cancer risk, such as BRCA2, may also benefit from earlier screening, sometimes in their early 40s. If you know you carry one of these mutations, bring it up with your doctor before age 45.
What Prostate Screening Actually Involves
Prostate screening today centers on a PSA blood test, a simple blood draw that measures a protein produced by the prostate. The widely used threshold is 4.0 ng/mL as the upper limit of normal, though what counts as “normal” shifts with age. For men in their 40s, a PSA above 2.5 ng/mL may warrant closer attention. For men in their 60s, the threshold is closer to 4.5 ng/mL.
A digital rectal exam, where a doctor physically checks the prostate for abnormalities, is less effective than the PSA test at detecting cancer on its own. It can, however, catch cancers that don’t raise PSA levels, so some doctors still include it as part of screening. If both tests are done at the same visit, the blood draw for PSA is typically done first, since a rectal exam may slightly elevate PSA levels.
It’s worth knowing that an elevated PSA does not mean you have cancer. About 75% of men with PSA levels above 4.0 ng/mL do not have prostate cancer. Benign prostate enlargement, infection, and inflammation can all push the number up. An abnormal result usually leads to repeat testing or additional tests before anyone considers a biopsy.
How Often to Get Tested
Your initial PSA result helps determine how frequently you need to be rescreened. If your first PSA is below 2.0 ng/mL, screening every two years is generally sufficient. At that level, the chance of PSA climbing into a concerning range within two years is extremely low, between 0% and 4%.
If your baseline PSA falls between 2.1 and 4.0 ng/mL, your doctor will likely recommend annual testing. About 27% of men with a PSA between 2.1 and 3.0 and 36% of men between 3.1 and 4.0 will see their levels rise into a range that needs further evaluation within two years. That’s a meaningful jump, so closer monitoring makes sense.
Preparing for a PSA Test
A few things can temporarily raise your PSA and lead to a false positive. Ejaculation causes a measurable spike in PSA levels, particularly within the first hour. Most doctors recommend abstaining for at least 48 to 72 hours before your blood draw. Vigorous cycling, urinary tract infections, and any recent prostate procedure can also inflate the number. If your PSA comes back elevated and you didn’t avoid these factors, a repeat test under better conditions is a reasonable next step.
Why Screening Is a Conversation, Not a Routine Order
Unlike blood pressure checks or cholesterol panels, prostate screening isn’t automatically recommended for every man at a certain age. The U.S. Preventive Services Task Force classifies it as a decision that is “likely to be sensitive to individual patient preferences.” The reason: prostate cancer screening catches many slow-growing cancers that would never cause symptoms or shorten a man’s life. Treating those cancers can lead to side effects like urinary incontinence and erectile dysfunction, so detecting them isn’t always a net benefit.
This doesn’t mean screening is bad. It means you and your doctor should weigh your personal risk (age, race, family history, overall health) against the possibility of overdiagnosis. For men at higher risk, the math tilts clearly toward screening. For men at average risk, it’s a genuine tradeoff worth discussing honestly.
Symptoms That Warrant an Earlier Check
Screening is for men without symptoms. If you’re experiencing certain changes, a prostate evaluation is appropriate regardless of your age or screening schedule. Symptoms that should prompt a visit include:
- Frequent nighttime urination (waking up multiple times to urinate)
- Weak or intermittent urine stream
- Hesitancy (difficulty starting urination)
- Urgency or urinary retention
- Blood in the urine
- Erectile dysfunction
Each of these symptoms individually has a relatively low chance of pointing to cancer, with positive predictive values around 2% to 3% in primary care settings. Most of the time, urinary symptoms in men over 50 stem from benign prostate enlargement. But because the overlap exists, these symptoms warrant a PSA test and rectal exam to rule cancer out. Visible blood in the urine is considered a high-risk symptom for urological cancers more broadly and should always be evaluated promptly.
When Screening Stops
Most guidelines suggest stopping routine prostate screening around age 70 or when a man’s life expectancy falls below 10 years. Prostate cancer typically grows slowly, and the harms of treatment tend to outweigh the benefits in older men or those with serious competing health conditions. If you’ve been screened regularly and your PSA has remained consistently low, discontinuing after 70 is a reasonable choice for most men.